Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Letrozole plus misoprostol for induced abortion
IRCT2017011526962N3Phase 3Completed
- Sponsor
- Vice Chancellor for Research Urmia university of medical sciences
- Start
- Jan 2017
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of letrozole and misoprostol in Induced Abortion (TOP) (2 arms), sponsored by Vice Chancellor for Research Urmia university of medical sciences. Primary endpoint: Induced abortion success rate. Started Jan 2017; status: completed.
02
Drugs
letrozolemisoprostol
03
Conditions
Induced Abortion (TOP)
Beyond the preview
Go deeper on IRCT2017011526962N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2017011526962N3.